1887

Abstract

Two antigenic sites recognized by neutralizing monoclonal antibodies (MAbs) directed against the fusion (F) glycoprotein of human respiratory syncytial virus were mapped on the primary structure of the protein by (i) the identification of amino acid substitutions selected in antibody-escape mutants and (ii) the reactivity of synthetic peptides with MAbs. The first site contained several overlapping epitopes which were located within the trypsin-resistant amino-terminal third of the large F1 subunit. Only one of these epitopes was faithfully reproduced by a short synthetic peptide; the others might require specific local conformations to react with MAbs. The second antigenic site was located in a trypsin-sensitive domain of the F1 subunit towards the carboxy-terminal end of the cysteine-rich region. One of these epitopes was reproduced by synthetic peptides. In addition, mutagenized F protein with a substitution of serine for arginine at position 429 did not bind MAbs to the second site. These results are discussed in terms of F protein structure and the mechanisms of virus neutralization.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-9-2225
1992-09-01
2021-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/9/JV0730092225.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-9-2225&mimeType=html&fmt=ahah

References

  1. Air G. M. 1989; Nucleotide sequence coding for the “signal peptide” and the N terminus of the hemagglutinin from an Asian (H2N2) strain of influenza virus. Virology 97:468–472
    [Google Scholar]
  2. Anderson L. J., Bingham P., Heirholzer J. C. 1988; Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. Journal of Virology 62:4235–4238
    [Google Scholar]
  3. Beeler J. A., van Wyke Coelingh K. 1989; Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. Journal of Virology 63:2941–2950
    [Google Scholar]
  4. Belshe R. B., van Voris L. P., Mufson M. A. 1982; Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. Journal of Infectious Diseases 145:311–319
    [Google Scholar]
  5. Bourgeois C., Corvaisier C., Bour J. B., Kohli E., Pothier P. 1991; Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. Journal of General Virology 72:1051–1058
    [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., Macdonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
  7. Collins P. L., Huang Y. T., Wertz G. W. 1984; Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proceedings of the National Academy of Sciences, U.S.A. 81:7683–7687
    [Google Scholar]
  8. Cristina J., Lopez J. A., Albo C., Garcia-Barreno B., Garcia J., Melero J. A., Portela A. 1990; Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology 174:126–134
    [Google Scholar]
  9. Daniels R. S., Downie J. C., Hay A. J., Knossow M., Skehel J. J., Wang M. L., Wiley D. C. 1985; Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431–439
    [Google Scholar]
  10. DeBorde D. C., Naeve C. W., Herlocher M. L., Maassab H. F. 1986; Resolution of a common RNA sequencing ambiguity by terminal deoxynucleotidyl transferase. Analytical Biochemistry 157:275–282
    [Google Scholar]
  11. Fuerst T. R., Niles E. G., Studier F. W., Moss B. 1986; Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proceedings of the National Academy of Sciences, U.S.A. 83:8122–8126
    [Google Scholar]
  12. Garcia-barreno B., Jorcano J. L., Aukenbauer T., Lopez-Galindez C., Melero J. A. 1988; Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Research 9:307–322
    [Google Scholar]
  13. Garcia-Barreno B., Palomo C., Penas C., Delgado T., Perez-Brena P., Melero J. A. 1989; Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. Journal of Virology 63:925–932
    [Google Scholar]
  14. Glezen W. P., Paredes P., Allison J. A., Taber L. H., Frank A. L. 1981; Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. Journal of Pediatrics 98:708–715
    [Google Scholar]
  15. Glezen W. P., Taber L. H., Frank A. L., Kasel J. A. 1986; Risk of primary infection and reinfection with respiratory syncytial virus. American Journal of Diseases of Children 140:543–546
    [Google Scholar]
  16. Gruber C., Levine S. 1983; Respiratory syncytial virus polypeptides. III. The envelope-associated proteins. Journal of Genera! Virology 64:825–832
    [Google Scholar]
  17. Hall C. B., Walsh E. E., Long C. E., Schnabel K. C. 1991; Immunity to and frequency of reinfection with respiratory syncytial virus. Journal of Infectious Diseases 163:693–698
    [Google Scholar]
  18. Ho S. N., Hunt H. D., Horton R. M., Pullen J. K., Pease L. R. 1989; Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59
    [Google Scholar]
  19. Huang Y. T., Wertz G. W. 1983; Respiratory syncytial virus mRNA coding assignments. Journal of Virology 46:667–672
    [Google Scholar]
  20. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. 1988; Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. Journal of General Virology 69:3023–3032
    [Google Scholar]
  21. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
    [Google Scholar]
  22. Lamprecht C. L., Krause H. E., Mufson M. A. 1976; Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. Journal of Infectious Diseases 134:211–217
    [Google Scholar]
  23. Lopez J. A., Villanueva N., Melero J. A., Portela A. 1988; Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Research 10:249–262
    [Google Scholar]
  24. Lopez J. A., Peñas C., Garcia-Barreno B., Melero J. A., Portela A. 1990; Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus. Journal of Virology 64:927–930
    [Google Scholar]
  25. McIntosh K., Chanock R. M. 1990; Respiratory syncytial virus. In Virology pp 1045–1072 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  26. Martin-Gallardo A., Fien K. A., Hu B. T., Farley J. F., Seid R., Collins P. L., Hildreth S. W., Paradiso P. R. 1991; Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitope. Virology 184:428–432
    [Google Scholar]
  27. Merrifield B. 1986; Solid phase synthesis. Science 232:341–347
    [Google Scholar]
  28. Morrison T. G. 1988; Structure, function and intracellular processing of paramyxovirus membrane proteins. Virus Research 10:113–136
    [Google Scholar]
  29. Murphy B. R., Prince G. A., Walsh E. E., Kim H. W., Parrott R. H., Hemming V. G., Rodriguez W. J., Chanock R. M. 1986; Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. Journal of Clinical Microbiology 24:197–202
    [Google Scholar]
  30. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. 1986; Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A. 83:7462–7466
    [Google Scholar]
  31. Palomo C., Albar J. P., Garcia-Barreno B., Melero J. A. 1990; Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies. Journal of Virology 64:4199–4206
    [Google Scholar]
  32. Palomo C., García-Barreno B., Peñas C., Melero J. A. 1991; The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. Journal of General Virology 72:669–675
    [Google Scholar]
  33. Parry N., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., Stuart D. 1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature, London 347:569–572
    [Google Scholar]
  34. Portela A., Rodriguez J. R., Rodriguez D., Rodriguez F., Garcia-Barreno B., Melero J. A., Esteban M. 1989; Expression of the fusion (F) protein of human respiratory syncytial virus using an attenuated strain of vaccinia virus. In Genetics and Pathogenicity of Negative Strand Viruses pp 74–78 Edited by Kolakofsky D., Mahy B. W. J. Amsterdam: Elsevier/ North-Holland;
    [Google Scholar]
  35. Prince G. A., Jenson A. B., Hemming V. G., Murphy B. R., Walsh E. E., Horswood R. L., Chanock R. M. 1986; Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. Journal of Virology 57:721–728
    [Google Scholar]
  36. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
  37. Scopes G. E., Watt P. J., Lambden P. R. 1990; Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus. Journal of General Virology 71:53–59
    [Google Scholar]
  38. Stott E. J., Taylor G., Ball L. A., Anderson K., Young K. K.-Y., King A. Q. M., Wertz G. W. 1987; Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
    [Google Scholar]
  39. Studier F. W. 1973; Analysis of bacteriophage T7 early mRNAs and proteins on slab gels. Journal of Molecular Biology 79:237–248
    [Google Scholar]
  40. Taylor G., Stott E. J., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett J. 1984; Monoclonal antibodies that protect against respiratory syncytial virus infection in mice. Immunology 52:137–142
    [Google Scholar]
  41. Taylor G., Stott E. J., Furze J., Ford J., Sopp P. 1992; Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. Journal of General Virology 73:2217–2223
    [Google Scholar]
  42. Trifilieff E., Dubs M. C., Van Regenmortel M. H. V. 1991; Antigenic cross-reactivity potential of synthetic peptides immobilized on polyethylene rods. Molecular Immunology 28:889–896
    [Google Scholar]
  43. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
  44. Trudel M., Nadon F., Seguin C., Dionne G., Lacroix M. 1987; Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. Journal of General Virology 68:2273–2280
    [Google Scholar]
  45. Trudel M., Stott E. J., Taylor G., Oth D., Mercier G., Nadon F., Seguin C., Simard C., Lacroix M. 1991; Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection. Archives of Virology 117:59–71
    [Google Scholar]
  46. Walsh E. E., Brandriss M. W., Schlesinger J. J. 1985; Purification and characterization of the respiratory syncytial virus fusion protein. Journal of General Virology 66:409–415
    [Google Scholar]
  47. Walsh E. E., Hall C. B., Briselli M., Brandriss M. W., Schlesinger J. J. 1987; Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. Journal of Infectious Diseases 155:1198–1204
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-9-2225
Loading
/content/journal/jgv/10.1099/0022-1317-73-9-2225
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error